This Site Is Intended for US Healthcare Professionals Only
3 INDICATIONS VOQUEZNA® (vonoprazan) is indicated for the healing of all grades of Erosive Esophagitis in adults Read More

GERD consists of 2 main forms: Non-Erosive GERD and Erosive GERD1

GERD affects ~65 million people in the US and can negatively impact their lives2,3

Approximately 45 million people in the US have Non-Erosive GERD, and approximately 20 million people in the US have Erosive GERD

54% of patients report persistent symptoms
despite daily PPI use4, *

*2015 National Gastrointestinal Survey involving 3,229 US participants on daily PPIs.4

About 80% of patients experience a recurrence of Erosive GERD within 6 months of stopping treatment

Recurrence of Erosive GERD is associated with its initial severity.7

73% of healthcare providers recommend patients add OTC drugs to control Erosive GERD